Gender-affirming care may reduce the risk of HIV among trans, nonbinary and gender-diverse people
Gender-affirming hormone therapy (GAHT) is associated with significantly improved HIV outcomes for transgender, nonbinary, ...
Infectious Disease Advisor14hOpinion
Reversal of Progress: Protecting Gender-Affirming Care in Trump’s America
In the first days of Donald Trump’s second term as United States president, he signed 2 executive orders that carry ...
Neurology Advisor13h
Gender-Affirming Hormone Therapy in Primary Care Tied to Reduced Depressive Symptoms
Gender-affirming hormone therapy in primary care is associated with lower rates of depressive symptoms in US transgender, nonbinary, and gender-diverse adults over 4 years of follow-up.
5 People Share Their Positive Personal Experiences with Gender-Affirming Care
The right-wing crusade against transgender people has led to an assault on this lifesaving treatment. (Irresponsible media ...